HCC tumorous tissue; corresponding adjacent non-tumorous tissue; serum; lung metastatic tissue; xenograft tumor tissue
HepG2; Huh7; SMMC-7721; Focus; MHCC-97L; MHCC-97H; L02
cell line-derived xenograft
glycolysis (promotes); proliferation (promotes); migration (promotes); invasion (promotes); metastasis (promotes); apoptosis (inhibits); ceRNA regulation (promotes); mitochondrial function (inhibits); other pathway/process (promotes)
Back-Splice Junction PCR / divergent primers PCR; RNase R Treatment; Sanger Sequencing; Actinomycin D / DRB Stability Assay; RT-qPCR; Microarray; FISH / smFISH; Nuclear-Cytoplasmic Fractionation; Clinical Sample Validation; RIP (RNA Immunoprecipitation); RNA Pull-Down; Luciferase Reporter Assay; Transfection; CCK8; EdU Staining; Colony Formation Assay; Annexin V/PI Flow Cytometry; Transwell Assay; Wound Healing Assay; In Vivo Animal Model; H&E Staining; IHC (Immunohistochemistry); Western Blot; Cohort Study; Survival Analysis; Bioinformatics Analysis
High circMAT2B expression predicts poor overall survival and is correlated with tumor size, vascular invasion, tumor multiplicity, tumor encapsulation, tumor-node-metastasis stage, Edmonson stage, and higher PET/CT SUVmax in HCC patients.
circMAT2B is up-regulated in HCC tissues and cell lines and high expression predicts poor overall survival. It promotes glycolysis, tumor growth, migration, invasion and metastasis under hypoxia by sponging miR-338-3p and up-regulating PKM2, suggesting therapeutic potential in HCC.
0.8981
Circular RNA MAT2B Promotes Glycolysis and Malignancy of Hepatocellular Carcinoma Through the miR-338-3p/PKM2 Axis Under Hypoxic Stress.
combined biological and clinical study